Biosimilars and generics as "rip-offs": when the facts may not matter
There are instances when a few well-chosen words are repositories of profound meaning and times when they betray a lack of understanding....
Neil Wilkof -
Friday, March 10, 2017
Biosimilars and generics as "rip-offs": when the facts may not matter
Reviewed by Neil Wilkof
on
Friday, March 10, 2017
Rating:
Reviewed by Neil Wilkof
on
Friday, March 10, 2017
Rating: